Alnylam Pharmaceuticals
ALNY
#651
Rank
HK$306.74 B
Marketcap
HK$2,298
Share price
0.68%
Change (1 day)
10.04%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company